James Armitage
Vermögen: 52 231 $ am 31.05.2026
Vermögen: 52 231 $ am 31.05.2026
Dr. James O.
Armitage, MD, is an Independent Director at Cardiff Oncology, Inc. and a Professor-Internal Medicine at University of Nebraska Medical Center.
He is on the Board of Directors at Cardiff Oncology, Inc. and Tesaro, Inc. Dr. Armitage was previously employed as a President by American Society for Blood & Marrow Transplantation and a President & Director by American Society of Clinical Oncology, Inc. He also served on the board at MGI PHARMA, Inc. He received his undergraduate degree from the University of Nebraska and a doctorate degree from the University of Nebraska Medical Center.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CARDIFF ONCOLOGY, INC. 0,04 % | 11.06.2026 | 27.490 ( 0,04 % ) | 52 231 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TESARO INC | Direktor/Vorstandsmitglied | 09.05.2013 |
| CARDIFF ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 22.04.2020 |
University of Nebraska Medical Center
University of Nebraska Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.1982 |
| Unternehmen | Position | Ende |
|---|---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology Develops. manufactures & markets pharmaceutical and medical products for therapeutic markets | Direktor/Vorstandsmitglied | 29.01.2008 |
American Society for Blood & Marrow Transplantation
American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation is a professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, advocacy, and clinical resources. It provides evidence-based practice guidelines, clinical calculators, coding and billing guides, educational courses, webinars, and publishes the peer-reviewed journal "Transplantation and Cellular Therapy." The society hosts scientific meetings, supports professional development, and collaborates with international organizations. Advocacy efforts focus on improving patient access to therapies, increasing NIH funding, and supporting critical programs. | Präsident | - |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Präsident | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology Develops. manufactures & markets pharmaceutical and medical products for therapeutic markets | Health Technology |
University of Nebraska
University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Cardiff Oncology, Inc.
Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
University of Nebraska Medical Center
University of Nebraska Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
American Society for Blood & Marrow Transplantation
American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation is a professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, advocacy, and clinical resources. It provides evidence-based practice guidelines, clinical calculators, coding and billing guides, educational courses, webinars, and publishes the peer-reviewed journal "Transplantation and Cellular Therapy." The society hosts scientific meetings, supports professional development, and collaborates with international organizations. Advocacy efforts focus on improving patient access to therapies, increasing NIH funding, and supporting critical programs. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen